Figure 2From: Li-Fraumeni syndrome with simultaneous osteosarcoma and liver cancer: Increased expression of a CD44 variant isoform after chemotherapy Transitional serum biomarkers for liver cancer and osteosarcoma. Combined therapy with surgical resection after chemotherapy resulted in a significant decrease in serum tumor markers for liver cancer and osteosarcoma. AFP and L-3 are serum markers for the hepatic tumor, whereas LDH and ALP are serum markers for the osteosarcomaBack to article page